Cellular senescence in oral cancer and precancer and treatment implications: A review

References

• Oliver RJ, Dearing J, Hindle I. Oral cancer in young adults: Report of three cases and review of the literature. Br Dent J 2000; 188: 362–5
   PubMed Web of Science ®Google Scholar
• Sudbo J, Reith A. The evolution of predictive oncology and molecular-based therapy for oral cancer prevention. Int J Cancer 2005; 115: 339–45
   PubMed Web of Science ®Google Scholar
• Centro Nacional de Epidemiología. Mortalidad por Cáncer y otras causas en España. http://193.146.50.130/htdocs/cancer//mort2002.txt. 2002. Ref Type: Electronic Citation.
   Google Scholar
• European Comission Health Monitoring Program. Comprehensive Cancer Monitoring Program in Europe-EUCAN. htpp://www.dep.iarc.fr/eucan/eucan.htm. 1998. Ref Type: Electronic Citation.
   Google Scholar
• Banoczy J, Gintner Z, Dombi C. Tobacco use and oral leukoplakia. J Dent Educ 2001; 65: 322–7
   PubMedGoogle Scholar
• Femiano F, Scully C. DNA cytometry of oral leukoplakia and oral lichen planus. Med Oral Patol Oral Cir Bucal 2005; 10(Suppl 1)E9–E14
   PubMedGoogle Scholar
• Scully C, Porter S. ABC of oral health. Oral cancer. BMJ 2000; 321(7253)97–100
   PubMed Web of Science ®Google Scholar
• Bettendorf O, Piffko J, Bankfalvi A. Prognostic and predictive factors in oral squamous cell cancer: Important tools for planning individual therapy?. Oral Oncol 2004; 40: 110–9
   PubMed Web of Science ®Google Scholar
• Werkmeister R, Brandt B, Joos U. Aberrations of erbB-1 and erbB-2 oncogenes in non-dysplastic leukoplakias of the oral cavity. Br J Oral Maxillofac Surg 1999; 37: 477–80
   PubMed Web of Science ®Google Scholar
• Campisi J, Kim SH, Lim CS, Rubio M. Cellular senescence, cancer and aging: The telomere connection. Exp Gerontol 2001; 36: 1619–37
   PubMed Web of Science ®Google Scholar
• Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961; 25: 585–621
   PubMed Web of Science ®Google Scholar
• Kim Sh SH, Kaminker P, Campisi J. Telomeres, aging and cancer: In search of a happy ending. Oncogene 2002; 21: 503–11
   PubMed Web of Science ®Google Scholar
• Campisi J. Cancer, aging and cellular senescence. In Vivo 2000; 14: 183–8
   PubMed Web of Science ®Google Scholar
• von Zglinicki T, Saretzki G, Ladhoff J, d'Adda dF, Jackson SP. Human cell senescence as a DNA damage response. Mech Ageing Dev 2005;126:111–7.
   PubMed Web of Science ®Google Scholar
• Mathon NF, Lloyd AC. Cell senescence and cancer. Nat Rev Cancer 2001; 1: 203–13
   PubMed Web of Science ®Google Scholar
• Roninson IB. Tumor cell senescence in cancer treatment. Cancer Res 2003; 63: 2705–15
   PubMed Web of Science ®Google Scholar
• Wei S, Wei S, Sedivy JM. Expression of catalytically active telomerase does not prevent premature senescence caused by overexpression of oncogenic Ha-Ras in normal human fibroblasts. Cancer Res 1999; 59: 1539–43
   PubMed Web of Science ®Google Scholar
• Dimri GP, Campisi J. Altered profile of transcription factor-binding activities in senescent human fibroblasts. Exp Cell Res 1994; 212: 132–40
   PubMed Web of Science ®Google Scholar
• Smith JR, Pereira-Smith OM. Replicative senescence: Implications for in vivo aging and tumor suppression. Science 1996; 273(5271)63–7
   PubMed Web of Science ®Google Scholar
• Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M, et al. Tumour biology: Senescence in premalignant tumours. Nature 2005; 436(7051)642
   PubMed Web of Science ®Google Scholar
• Collado M, Serrano M. The power and the promise of oncogene-induced senescence markers. Nat Rev Cancer 2006; 6: 472–6
   PubMed Web of Science ®Google Scholar
• Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B, et al. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 2005; 436(7051)660–5
   PubMed Web of Science ®Google Scholar
• Choi J, Shendrik I, Peacocke M, Peehl D, Buttyan R, Ikeguchi EF, et al. Expression of senescence-associated beta-galactosidase in enlarged prostates from men with benign prostatic hyperplasia. Urology 2000; 56: 160–6
   PubMed Web of Science ®Google Scholar
• Jennings BJ, Ozanne SE, Hales CN. Nutrition, oxidative damage, telomere shortening, and cellular senescence: Individual or connected agents of aging?. Mol Genet Metab 2000; 71: 32–42
   PubMed Web of Science ®Google Scholar
• Kirkwood TB, Austad SN. Why do we age?. Nature 2000; 408(6809)233–8
   PubMed Web of Science ®Google Scholar
• Campisi J, Warner RH. Aging in mitotic and post-mitotic cells. The role of DNA damage and repair in cell aging, BA Gilchrest, VA Bohr, 2001; 1–16
   Google Scholar
• Krtolica A, Parrinello S, Lockett S, Desprez PY, Campisi J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging. Proc Natl Acad Sci USA 2001; 98: 12072–7
   PubMed Web of Science ®Google Scholar
• Nickoloff BJ, Lingen MW, Chang BD, Shen M, Swift M, Curry J, et al. Tumor suppressor maspin is up-regulated during keratinocyte senescence, exerting a paracrine antiangiogenic activity. Cancer Res 2004; 64: 2956–61
   PubMed Web of Science ®Google Scholar
• Chang BD, Swift ME, Shen M, Fang J, Broude EV, Roninson IB. Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent. Proc Natl Acad Sci USA 2002; 99: 389–94
   PubMed Web of Science ®Google Scholar
• Campisi J. Senescent cells, tumor suppression, and organismal aging: Good citizens, bad neighbors. Cell 2005; 120: 513–22
   PubMed Web of Science ®Google Scholar
• Lee AC, Fenster BE, Ito H, Takeda K, Bae NS, Hirai T, et al. Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J Biol Chem 1999; 274: 7936–40
   PubMed Web of Science ®Google Scholar
• Beausejour CM, Krtolica A, Galimi F, Narita M, Lowe SW, Yaswen P, et al. Reversal of human cellular senescence: Roles of the p53 and p16 pathways. EMBO J 2003; 22: 4212–22
   PubMed Web of Science ®Google Scholar
• McGregor F, Muntoni A, Fleming J, Brown J, Felix DH, MacDonald DG, et al. Molecular changes associated with oral dysplasia progression and acquisition of immortality: Potential for its reversal by 5-azacytidine. Cancer Res 2002; 62: 4757–66
   PubMed Web of Science ®Google Scholar
• Warnakulasuriya KA, Tavassoli M, Johnson NW. Relationship of p53 overexpression to other cell cycle regulatory proteins in oral squamous cell carcinoma. J Oral Pathol Med 1998; 27: 376–81
   PubMed Web of Science ®Google Scholar
• Srinivasan M, Jewell SD. Evaluation of TGF-alpha and EGFR expression in oral leukoplakia and oral submucous fibrosis by quantitative immunohistochemistry. Oncology 2001; 61: 284–92
   PubMed Web of Science ®Google Scholar
• Kang MK, Park NH. Conversion of normal to malignant phenotype: Telomere shortening, telomerase activation, and genomic instability during immortalization of human oral keratinocytes. Crit Rev Oral Biol Med 2001; 12: 38–54
   PubMedGoogle Scholar
• Soni S, Kaur J, Kumar A, Chakravarti N, Mathur M, Bahadur S, et al. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma. Oncology 2005; 68: 314–25
   PubMed Web of Science ®Google Scholar
• Kwak IH, Kim HS, Choi OR, Ryu MS, Lim IK. Nuclear accumulation of globular actin as a cellular senescence marker. Cancer Res 2004; 64: 572–80
   PubMed Web of Science ®Google Scholar
• Kurz DJ, Decary S, Hong Y, Erusalimsky JD. Senescence-associated (beta)-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells. J Cell Sci 2000; 113(Pt 20)3613–22
   PubMed Web of Science ®Google Scholar
• Masumoto N, Fujii T, Ishikawa M, Saito M, Iwata T, Fukuchi T, et al. P16 overexpression and human papillomavirus infection in small cell carcinoma of the uterine cervix. Hum Pathol 2003; 34: 778–83
   PubMed Web of Science ®Google Scholar
• Natarajan E, Saeb M, Crum CP, Woo SB, McKee PH, Rheinwald JG. Co-expression of p16(INK4A] and laminin 5 gamma2 by microinvasive and superficial squamous cell carcinomas in vivo and by migrating wound and senescent keratinocytes in culture. Am J Pathol 2003; 163: 477–91
   PubMed Web of Science ®Google Scholar
• Konig F, Krekeler G, Honig JF, Cordon-Cardo C, Fischer G, Korabiowska M. Relation between human papillomavirus positivity and p16 expression in head and neck carcinomas--a tissue microarray study. Anticancer Res 2007; 27(1A)283–8
   PubMed Web of Science ®Google Scholar
• Okazaki Y, Tanaka Y, Tonogi M, Yamane G. Investigation of environmental factors for diagnosing malignant potential in oral epithelial dysplasia. Oral Oncol 2002; 38: 562–73
   PubMed Web of Science ®Google Scholar
• Bosch FX, Ritter D, Enders C, Flechtenmacher C, Abel U, Dietz A, et al. Head and neck tumor sites differ in prevalence and spectrum of p53 alterations but these have limited prognostic value. Int J Cancer 2004; 111: 530–8
   PubMed Web of Science ®Google Scholar
• Narita M, Nunez S, Heard E, Narita M, Lin AW, Hearn SA, et al. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003; 113: 703–16
   PubMed Web of Science ®Google Scholar
• Blacque OE, Worrall DM. Evidence for a direct interaction between the tumor suppressor serpin, maspin, and types I and III collagen. J Biol Chem 2002; 277: 10783–8
   PubMed Web of Science ®Google Scholar
• Cerni C. Telomeres, telomerase, and myc. An update. Mutat Res 2000; 462: 31–47
   PubMed Web of Science ®Google Scholar
• Harle-Bachor C, Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis inhuman skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 1996; 93: 6476–81
   PubMed Web of Science ®Google Scholar
• Kang MK, Kameta A, Shin KH, Baluda MA, Park NH. Senescence occurs with hTERT repression and limited telomere shortening in human oral keratinocytes cultured with feeder cells. J Cell Physiol 2004; 199: 364–70
   PubMed Web of Science ®Google Scholar
• Perkins ND, Felzien LK, Betts JC, Leung K, Beach DH, Nabel GJ. Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator. Science 1997; 275(5299)523–7
   PubMed Web of Science ®Google Scholar
• Malumbres M, Perez DC, I, Hernandez MI, Jimenez M, Corral T, Pellicer A. Cellular response to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15(INK4b]. Mol Cell Biol 2000;20:2915–25.
   PubMed Web of Science ®Google Scholar
• Liu X, Yue P, Khuri FR, Sun SY. Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity. Cancer Res 2005; 65: 9169–75
   PubMed Web of Science ®Google Scholar
• Chang BD, Xuan Y, Broude EV, Zhu H, Schott B, Fang J, et al. Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs. Oncogene 1999; 18: 4808–18
   PubMed Web of Science ®Google Scholar
• te Poele RH, Okorokov AL, Jardine L, Cummings J, Joel SP. DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res 2002; 62: 1876–83
   PubMed Web of Science ®Google Scholar
• Dokmanovic M, Chang BD, Fang J, Roninson IB. Retinoid-induced growth arrest of breast carcinoma cells involves co-activation of multiple growth-inhibitory genes. Cancer Biol Ther 2002; 1: 24–7
   PubMed Web of Science ®Google Scholar
• Bullock AN, Fersht AR. Rescuing the function of mutant p53. Nat Rev Cancer 2001; 1: 68–76
   PubMed Web of Science ®Google Scholar
• Foster BA, Coffey HA, Morin MJ, Rastinejad F. Pharmacological rescue of mutant p53 conformation and function. Science 1999; 286(5449)2507–10
   PubMed Web of Science ®Google Scholar
• Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M, et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 2005; 436(7051)725–30
   PubMed Web of Science ®Google Scholar